Scarica l'app Stockscreener
25.67
1.00%
-0.26
Dopo l'orario di chiusura:
25.67
Precedente Chiudi:
$25.93
Aprire:
$25.91
Volume 24 ore:
1.44M
Relative Volume:
1.31
Capitalizzazione di mercato:
$2.25B
Reddito:
$23.38M
Utile/perdita netta:
$-155.22M
Rapporto P/E:
-11.72
EPS:
-2.19
Flusso di cassa netto:
$-134.36M
1 W Prestazione:
+5.03%
1M Prestazione:
+2.19%
6M Prestazione:
+38.08%
1 anno Prestazione:
-18.17%
Intervallo 1D:
$25.61
$26.57
Intervallo di 1 settimana:
$24.95
$26.60
Portata 52W:
$13.45
$32.67
Ideaya Biosciences Inc Stock (IDYA) Company Profile
Nome
Ideaya Biosciences Inc
Settore
Industria
Telefono
650-443-6209
Indirizzo
5000 SHORELINE CT, SUITE 300, SOUTH SAN FRANCISCO, CA
Confronta IDYA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IDYA
Ideaya Biosciences Inc
|
25.67 | 2.27B | 23.38M | -155.22M | -134.36M | -2.19 |
|
VRTX
Vertex Pharmaceuticals Inc
|
376.62 | 97.36B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
576.98 | 60.19B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.37 | 59.56B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
729.76 | 44.94B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
329.84 | 36.14B | 3.81B | -644.79M | -669.77M | -6.24 |
Ideaya Biosciences Inc Stock (IDYA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-18 | Iniziato | Guggenheim | Buy |
| 2025-09-04 | Iniziato | Barclays | Overweight |
| 2025-09-04 | Iniziato | Citizens JMP | Mkt Outperform |
| 2025-07-22 | Iniziato | TD Cowen | Buy |
| 2025-07-10 | Ripresa | Goldman | Neutral |
| 2025-06-26 | Iniziato | Wells Fargo | Overweight |
| 2024-11-18 | Iniziato | Stephens | Overweight |
| 2024-11-05 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-10-24 | Iniziato | UBS | Buy |
| 2024-10-15 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-07-08 | Iniziato | Mizuho | Outperform |
| 2024-03-08 | Iniziato | BTIG Research | Buy |
| 2023-08-08 | Iniziato | SVB Securities | Outperform |
| 2023-05-24 | Iniziato | Goldman | Buy |
| 2023-04-24 | Aggiornamento | Stifel | Hold → Buy |
| 2023-03-23 | Iniziato | Berenberg | Buy |
| 2023-02-28 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-12-28 | Iniziato | CapitalOne | Overweight |
| 2022-10-27 | Iniziato | Citigroup | Buy |
| 2022-08-15 | Downgrade | Stifel | Buy → Hold |
| 2022-07-18 | Ripresa | Oppenheimer | Outperform |
| 2022-03-10 | Aggiornamento | Stifel | Hold → Buy |
| 2021-09-23 | Iniziato | Stifel | Hold |
| 2021-06-04 | Ripresa | Robert W. Baird | Outperform |
| 2021-03-11 | Iniziato | Guggenheim | Buy |
| 2020-10-07 | Iniziato | Wedbush | Outperform |
| 2020-09-01 | Iniziato | Northland Capital | Outperform |
| 2020-07-13 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-06-17 | Reiterato | H.C. Wainwright | Buy |
| 2020-04-06 | Iniziato | H.C. Wainwright | Buy |
| 2020-03-13 | Iniziato | ROTH Capital | Buy |
| 2019-10-17 | Iniziato | Oppenheimer | Outperform |
| 2019-09-10 | Iniziato | Robert W. Baird | Outperform |
| 2019-06-17 | Iniziato | Citigroup | Buy |
| 2019-06-17 | Iniziato | JP Morgan | Neutral |
| 2019-06-17 | Iniziato | Jefferies | Buy |
Mostra tutto
Ideaya Biosciences Inc Borsa (IDYA) Ultime notizie
UBS reiterates Buy rating on Ideaya Biosciences stock with $50 target - Investing.com
Guggenheim Begins Coverage on IDEAYA Biosciences (NASDAQ:IDYA) - MarketBeat
Rhumbline Advisers Boosts Holdings in IDEAYA Biosciences, Inc. $IDYA - MarketBeat
Investor Mood: Is IDEAYA Biosciences Inc. gaining market shareWeekly Gains Summary & Low Drawdown Momentum Trade Ideas - خودرو بانک
Is IDEAYA Biosciences Inc stock a top performer YTD2025 Volume Leaders & Fast Exit and Entry Strategy Plans - khodrobank.com
IDEAYA Biosciences Hits Day High with 7.28% Surge Amid Financial Struggles - Markets Mojo
Dip Buying: What drives IDEAYA Biosciences Incs stock priceWeekly Trend Report & Smart Investment Allocation Tips - خودرو بانک
Guidance Update: Is IDEAYA Biosciences Inc benefiting from innovation trends2025 Geopolitical Influence & High Win Rate Trade Tips - khodrobank.com
Will IDEAYA Biosciences Inc benefit from geopolitical trendsIndex Update & Real-Time Market Trend Scan - خودرو بانک
Update Recap: Is IDEAYA Biosciences Inc. benefiting from innovation trendsEarnings Growth Summary & Verified Technical Trade Signals - خودرو بانک
Take Profit: Whats the beta of IDEAYA Biosciences Inc stockJuly 2025 Closing Moves & Free Technical Confirmation Trade Alerts - khodrobank.com
Activity Recap: Is IDEAYA Biosciences Inc stock a good dividend stock2025 Technical Overview & AI Powered Trade Plan Recommendations - خودرو بانک
Buyback Watch: Will IDEAYA Biosciences Inc. outperform tech stocksWeekly Gains Summary & Weekly Watchlist for Hot Stocks - خودرو بانک
Setup Watch: Will IDEAYA Biosciences Inc benefit from geopolitical trendsShare Buyback & Risk Managed Investment Signals - khodrobank.com
IDEAYA Biosciences (NASDAQ:IDYA) Now Covered by Guggenheim - Defense World
Guggenheim Initiates Coverage of IDEAYA Biosciences (IDYA) with Buy Recommendation - Nasdaq
Market Pulse: Can IDEAYA Biosciences Inc. benefit from deglobalizationQuarterly Investment Review & Free Daily Entry Point Trade Alerts - خودرو بانک
Aug Macro: Can Skechers USA Inc stock outperform in a bear market2025 Buyback Activity & Low Drawdown Investment Ideas - khodrobank.com
Guggenheim Initiates Coverage on IDEAYA Biosciences (IDYA) with a Buy Rating | IDYA Stock News - GuruFocus
Growth Report: Is IDEAYA Biosciences Inc. stock a good dividend stockWeekly Market Summary & Weekly Top Performers Watchlists - خودرو بانک
Aug Patterns: Is IDEAYA Biosciences Inc. benefiting from innovation trendsJuly 2025 Drop Watch & Risk Managed Investment Signals - khodrobank.com
IDEAYA Biosciences, Inc. $IDYA Shares Sold by Woodline Partners LP - MarketBeat
IDEAYA Biosciences’ SWOT analysis: promising data boosts stock outlook - Investing.com India
Guggenheim Initiates IDEAYA Biosciences(IDYA.US) With Buy Rating, Announces Target Price $50 - 富途牛牛
IDEAYA Biosciences’ SWOT analysis: promising data boosts stock outlook By Investing.com - Investing.com Canada
Pullback Watch: Will IDEAYA Biosciences Inc. benefit from geopolitical trendsEarnings Risk Report & Low Risk Growth Stock Ideas - khodrobank.com
IDEAYA Biosciences (NASDAQ:IDYA) Given New $44.00 Price Target at Mizuho - MarketBeat
Leerink Partnrs Has Bearish Outlook for IDYA FY2026 Earnings - MarketBeat
Published on: 2025-09-17 01:19:00 - خودرو بانک
IDEAYA Biosciences Stock Price, Quotes and Forecasts | NASDAQ:IDYA - Benzinga
Revenue Check: Is IDEAYA Biosciences Inc subject to activist investor interestJuly 2025 Catalysts & Expert-Curated Trade Recommendations - khodrobank.com
Published on: 2025-09-16 20:28:28 - خودرو بانک
Bond Watch: Is IDEAYA Biosciences Inc likely to announce a buybackWeekly Gains Report & Risk Managed Investment Strategies - خودرو بانک
IPO Launch: Can IDEAYA Biosciences Inc reach all time highs this yearJuly 2025 Summary & Reliable Intraday Trade Alerts - خودرو بانک
Should you hold or exit IDEAYA Biosciences Inc. now2025 Year in Review & Weekly Watchlist for Consistent Profits - newser.com
Can IDEAYA Biosciences Inc reach all time highs this yearWeekly Gains Report & Safe Capital Growth Stock Tips - خودرو بانک
Trend Review: How cyclical is Ameriprise Financial Inc.’s revenue streamMarket Performance Recap & High Accuracy Trade Alerts - خودرو بانک
Aug Sectors: Is IDEAYA Biosciences Inc a good stock for dollar cost averaging2025 Market Overview & Verified Technical Trade Signals - خودرو بانک
Sentiment Watch: Will IDEAYA Biosciences Inc. outperform small cap indexes2025 Short Interest & Safe Capital Growth Tips - خودرو بانک
Signal Recap: Is IDEAYA Biosciences Inc. likely to announce a buybackWeekly Trading Summary & Expert Approved Trade Ideas - khodrobank.com
Is IDEAYA Biosciences Inc.’s ROIC above industry averageJuly 2025 Review & Risk Managed Trade Strategies - khodrobank.com
Published on: 2025-09-15 13:23:10 - khodrobank.com
What’s IDEAYA Biosciences Inc.’s historical returnQuarterly Profit Report & Accurate Buy Signal Alerts - خودرو بانک
Research Analysts’ Recent Ratings Changes for IDEAYA Biosciences (IDYA) - Defense World
Using Bollinger Bands to evaluate IDEAYA Biosciences Inc.Forecast Cut & Precise Buy Zone Identification - newser.com
IDEAYA Biosciences (NASDAQ:IDYA) Receives "Overweight" Rating from Cantor Fitzgerald - MarketBeat
Mizuho Forecasts Strong Price Appreciation for IDEAYA Biosciences (NASDAQ:IDYA) Stock - Defense World
Stephens Reiterates Overweight Rating for IDEAYA Biosciences (NASDAQ:IDYA) - MarketBeat
Ideaya Biosciences gets coverage initiation at Barclays and Citizens - MSN
Could IDEAYA Biosciences' (IDYA) Expanding Pipeline Redefine Its Long-Term Value Proposition? - Yahoo
IDEAYA Biosciences, Inc. $IDYA Shares Sold by Trexquant Investment LP - MarketBeat
Ideaya Biosciences Inc Azioni (IDYA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.30%
2.51%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):